Rodrigo González

Prolonged Survival of Dendritic Cell–Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor β-Expressing T Cells

Mercedes López, Cristián Pereda, Gabriela Segal et al. · Journal of Clinical Oncology · 2009 · 129 citations · Full text

Life Sciences, Immunology, Oncology +17

Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients

Alejandro Escobar, Mercedes López, Antonio E. Serrano et al. · Clinical & Experimental Immunology · 2005 · 103 citations · Full text

Medicine, Immunology, Oncology +15

A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines

Paulina A García-González, Rodrigo A. Morales, Lorena Hoyos et al. · Journal of Translational Medicine · 2013 · 43 citations · Full text

Life Sciences, Immunology, Immunoregulation +14

Tolerogenic Dendritic Cells Derived from Donors with Natural Rubber Latex Allergy Modulate Allergen-Specific T-Cell Responses and IgE Production

Alejandro Escobar, Adam Aguirre, María Antonieta Guzmán et al. · PLoS ONE · 2014 · 37 citations · Full text

Life Sciences, Immunology, Pharmacology +17

The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses

Claudia Duran‐Aniotz, Gabriela Segal, Lorena Salazar et al. · Cancer Immunology Immunotherapy · 2012 · 25 citations · Full text

Life Sciences, Immunology, Oncology +17